Approval · Notice of Compliance 1835 · 1999
RAXAR: Notice of Compliance 1835
Issued June 29, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1835
- Date
- June 29, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised dosage regimen
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAXAR | Not yet assigned | — |
Medicinal ingredients
- GREPAFLOXACIN HYDROCHLORIDE 200 MG per TAB